Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Contentment

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    9 result(s) found for: Contentment. Displaying page 1 of 1.
    EudraCT Number: 2010-024534-38 Sponsor Protocol Number: Version 1.1 Start Date*: 2011-07-19
    Sponsor Name:Medizinische Universität Wien, Abteilung für Herzchirurgie
    Full Title: Pilot-Trial: Dabigatran as an alternative anticoagulant in patients with left ventricular assist device
    Medical condition: patients with implanted left ventricular assist device
    Disease: Version SOC Term Classification Code Term Level
    13.1 10042613 - Surgical and medical procedures 10052374 Left ventricular assist device insertion LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2019-001725-27 Sponsor Protocol Number: KKSH152 Start Date*: 2019-10-24
    Sponsor Name:Martin-Luther-Universität Halle-Wittenberg
    Full Title: A randomized, open, three-arm comparative study of modern methods of postoperative pain therapy in patients with knee endoprostheses.
    Medical condition: Postoperative pain therapy after implantation of a knee endoprosthesis
    Disease: Version SOC Term Classification Code Term Level
    21.1 10042613 - Surgical and medical procedures 10036276 Postoperative analgesia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-001403-12 Sponsor Protocol Number: CARDIF Start Date*: 2012-03-14
    Sponsor Name:Charite Universitaetsmedizin Berlin
    Full Title: Carbon Dioxide for the Treatment of Febrile Seizures
    Medical condition: febrile seizures
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-010966-47 Sponsor Protocol Number: NeSSy_200901 Start Date*: 2010-01-13
    Sponsor Name:Universität Bremen
    Full Title: Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients...
    Medical condition: Schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10039626 Schizophrenia PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-001770-33 Sponsor Protocol Number: CRC-AGA01 Start Date*: 2008-05-15
    Sponsor Name:Charité-Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie, CRC
    Full Title: INVESTIGATOR-INITIATED SINGLE BLIND, TWO-ARMED, RANDOMIZED PHASE 3 CLINICAL TRIAL TO COMPARE EFFICACY OF 5% MINOXIDIL TOPICAL FOAM (5% MTF) ONCE DAILY VERSUS 2% MINOXIDIL TOPICAL SOLUTION (2% MTS) ...
    Medical condition: Women above 18 years old with slightly to moderate androgenetic alopecia (AGA), otherwise in general good health. The subjects have to show a female pattern type of AGA, Savin scale D3-D6 and a hai...
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-022114-12 Sponsor Protocol Number: MW012 Start Date*: 2010-12-20
    Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG
    Full Title: Multizentrische prospektive randomisierte kontrollierte offene Phase IV Studie zur Evaluation von Synergien zwischen WS® 1070 und strukturiertem Stressmanagement bei Patienten mit nachlassender Lei...
    Medical condition: Asthenia and decreased concentration capacity as well as fatigue and feeling of weakness along with subjective stress
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-023942-63 Sponsor Protocol Number: 10-017 Start Date*: 2011-01-17
    Sponsor Name:Clinical Trials Center Aachen, University of Aachen
    Full Title: The safety and feasibility of delivering xenon to patients before and after coronary artery bypass graft implantation: a pilot study Abbreviated study title: A pre- and post-Coronary Artery bypass...
    Medical condition: The aim of this study is to determine whether xenon and remifentanil – as compared to sevoflurane and remifentanil – can be applied safely in patients after CABG implantation for the remaining surg...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10002323 Anesthesia general LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-002370-12 Sponsor Protocol Number: IMI2016-2 Start Date*: 2016-12-29
    Sponsor Name:Charité Universitätsmedizin Berlin
    Full Title: PROOF OF CONCEPT STUDY OF HYQVIA IN PATIENTS WITH IMMUNOGLOBULIN DEFICIENCY AND RECURRENT INFECTIONS WITH CHRONIC FATIGUE SYNDROME
    Medical condition: Immunoglobulin deficiency and recurrent infections with chronic fatigue syndrome
    Disease: Version SOC Term Classification Code Term Level
    19.0 10018065 - General disorders and administration site conditions 10008874 Chronic fatigue syndrome PT
    19.0 100000004848 10021485 Immunoglobulin G decreased LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2021-003898-59 Sponsor Protocol Number: EFC17262 Start Date*: 2021-11-12
    Sponsor Name:SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
    Full Title: A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of tolebrutinib (SAR442168) in adults with generalized myasthenia gravis (MG)
    Medical condition: Myasthenia gravis
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029205 - Nervous system disorders 10028417 Myasthenia gravis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended) ES (Prematurely Ended) PL (Completed) HU (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 17 13:29:40 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA